Viewing data from:

ACEBUTOLOL HYDROCHLORIDE

ANDA

ACEBUTOLOL HYDROCHLORIDE | A074007 | ANI PHARMACEUTICALS INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$0.8176

per ea

Lowest NADAC/Unit

$0.5753

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
62559025601ACEBUTOLOL 400 MG CAPSULE	$0.8176	EA	Generic	—	2026-06-17
62559025501ACEBUTOLOL 200 MG CAPSULE	$0.5753	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$41.62

Highest Price

$96.00

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51407-0666-01ACEBUTOLOL HCL 200MG CAP	$41.62	FSS	Golden State Medical Supply, Inc.	06/14/2028
51407-0667-01ACEBUTOLOL HCL 400MG CAP	$96.00	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain2 active DMFs7 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

MOEHS IBERICA SLACEBUTOLOL

DMF 144201999

SS PHARMA LLCACEBUTOLOL HYDROCHLORIDE USP

DMF 358572021

ERREGIERRE SPAInactiveACEBUTOLOL HYDROCHLORIDE

DMF 79901989

QUIMICA SINTETICA SAInactiveACEBUTOLOL HYDROCHLORIDE

DMF 88741990

CAMBREX PROFARMACO MILANO SRLInactiveACEBUTOLOL HYDROCHLORIDE

DMF 93761991

SANOFI CHIMIEInactiveACEBUTOLOL HYDROCHLORIDE

DMF 93821991

LUSOCHIMICA SPAInactiveACEBUTOLOL HYDROCHLORIDE

DMF 94421991

SOLCHEM ITALIANA SPAInactiveACEBUTOLOL HYDROCHLORIDE

DMF 96641992

GENZYME CORPInactiveACEBUTOLOL HYDROCHLORIDE

DMF 99571992

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — EQ 200MG BASE

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Oct 18, 1995

No patent or exclusivity listings for this strength.

#002 — EQ 400MG BASE

0 patents0 exclusivities▾

CAPSULE;ORAL | Approved: Oct 18, 1995